Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell MBRace Therapeutics Stock

MBRace Therapeutics Stock

www.mbracetrx.com/Healthcare / BioTech & PharmaFounded: 2020

MBrace Therapeutics is dedicated to transforming cancer treatment through innovative discovery, aiming to translate research into transformative therapies for cancer patients. The team comprises experienced experts across cancer drug development, working together to offer new and improved treatment options. MBrace's approach integrates the expertise of researchers, the needs of patients, the guidance of physicians, and the team's dedication, fostering advancements in cancer therapeutics. Each team member's personal experience with cancer underpins their commitment to patient care, driving the development of novel treatment options.

Buy or sell MBRace Therapeutics stockLearn more about MBRace Therapeutics IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for MBRace Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access MBRace Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like MBRace Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

MBRace Therapeutics investors also invested in these private companies

Venrock
Alta Partners
TPG
Avidity Partners
Cowen Healthcare Investments

Team

Management Team

Yongjian Wu Ph.D
Chief Development Officer & Head of CMC
Renata Pasqualini Ph.D
Co-Founder, Chief Scientific Officer & Scientific Advisor
Isan Chen MD
Co-Founder, Chief Executive Officer & President
Wadih Arap Ph.D
Co-Founder & Scientific Advisor

Board Members

Carolyn Ng Ph.D
TPG
Eric Pham Ph.D
Cowen Healthcare Investments
Mariana Mihalusova
Venrock
Monal Mehta Ph.D
Avidity Partners
Racquel Bracken
Venrock
Robert More
Alta Partners

MBRace Therapeutics stock FAQs

plusminus

Can you buy MBRace Therapeutics stock?

As MBRace Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like MBRace Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy MBRace Therapeutics stock?

To invest in a private company like MBRace Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell MBRace Therapeutics stock?

Yes, you may be able to sell your MBRace Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell MBRace Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your MBRace Therapeutics stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is MBRace Therapeutics a public company?

No, MBRace Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is MBRace Therapeutics’ stock price?

MBRace Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access MBRace Therapeutics’ private market stock price with Forge Data.
plusminus

What is MBRace Therapeutics’ stock ticker symbol?

MBRace Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like MBRace Therapeutics in the BioTech & Pharma sector

Colossal Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B
Altos Labs
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B
ADARx Pharmaceuticals
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM
Cytonics
Sector
Healthcare / BioTech & Pharma
 
 
AI Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM
Egenesis
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$333.77MM
Apnimed
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$366.58MM
Pendulum Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM
BillionToOne
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.25B
FinSMEs 11/14/2023

MBrace Therapeutics Raises $85M in Series B Financing

MBrace Therapeutics, a San Diego, CA-based biopharmaceutical company, raised $85M in Series B funding. The round, which brought the total amount to $110M, was led by TPG, investing through its dedicated life sciences fund, TPG Life Sciences Innovations (TPG LSI), and its multi-sector impact strategy, The Rise Fund. The round also included new investors Avidity Partners and Cowen Healthcare Investments, as well as existing Series A investors, Venrock and Alta Partners.
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.